These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26339743)

  • 1. Letter to the Editor: High Serum N(1)-Methylnicotinamide in Obesity and Diabetes: A Consequence of Excess Nicotinamide?
    Zhou SS; Li D; Zhou Y
    J Clin Endocrinol Metab; 2015 Sep; 100(9):L78-9. PubMed ID: 26339743
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? Reply to Zhou S, Li D, Zhou Y [letter].
    Kannt A; Pfenninger A; Tönjes A; Blüher M
    Diabetologia; 2015 Sep; 58(9):2193-4. PubMed ID: 26113421
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.
    Liu M; Li L; Chu J; Zhu B; Zhang Q; Yin X; Jiang W; Dai G; Ju W; Wang Z; Yang Q; Fang Z
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3112-7. PubMed ID: 26066674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake?
    Zhou SS; Li D; Zhou Y
    Diabetologia; 2015 Sep; 58(9):2191-2. PubMed ID: 26122878
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the Letter by Zhou, et al.
    Liu M; Fang ZY; Yang Q
    J Clin Endocrinol Metab; 2015 Sep; 100(9):L80-1. PubMed ID: 26339744
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
    Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
    Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
    Liu M; Chu J; Gu Y; Shi H; Zhang R; Wang L; Chen J; Shen L; Yu P; Chen X; Ju W; Wang Z
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production.
    Pumpo R; Sarnelli G; Spinella A; Budillon G; Cuomo R
    Am J Gastroenterol; 2001 Apr; 96(4):1183-7. PubMed ID: 11316167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.
    Esteghamati A; Alamdari A; Zandieh A; Elahi S; Khalilzadeh O; Nakhjavani M; Meysamie A
    Diabetes Res Clin Pract; 2011 Feb; 91(2):154-8. PubMed ID: 21122936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.
    Sandeep S; Velmurugan K; Deepa R; Mohan V
    Metabolism; 2007 Apr; 56(4):565-70. PubMed ID: 17379018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes that control the conversion of L-tryptophan-nicotinamide and the urinary excretion ratio (N(1)-methyl-2-pyridone-5-carboxamide + N(1)-methyl-4-pyridone-3-carboxamide)/N(1)-methylnicotinamide in mice.
    Shibata K; Morita N; Shibata Y; Fukuwatari T
    Biosci Biotechnol Biochem; 2013; 77(10):2105-11. PubMed ID: 24096677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
    Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
    J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorimetric method for quantitation in the picomole range of N1-methylnicotinamide and nicotinamide in serum.
    Clark BR; Halpern RM; Smith RA
    Anal Biochem; 1975 Sep; 68(1):54-61. PubMed ID: 127534
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of nicotinamide intake on urinary excretion of N1-methylnicotinamide and oxidation of [7a-14C]tryptophan in the rat.
    Patterson JI; Harper AE
    J Nutr; 1982 Apr; 112(4):776-81. PubMed ID: 6461734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorometric quantitation of picomole amounts of 1-methylnicotinamide and nicotinamide in serum.
    Clark BR
    Methods Enzymol; 1980; 66():5-8. PubMed ID: 6445475
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered distribution and excretion of N-1-methylnicotinamide in rats with Walker 256 carcinosarcoma.
    Clark BR; Murai JT; Pomeranz A; Mills PA; Halpern RM
    Cancer Res; 1975 Jul; 35(7):1727-33. PubMed ID: 236826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess nicotinamide increases plasma serotonin and histamine levels.
    Tian YJ; Li D; Ma Q; Gu XY; Guo M; Lun YZ; Sun WP; Wang XY; Cao Y; Zhou SS
    Sheng Li Xue Bao; 2013 Feb; 65(1):33-8. PubMed ID: 23426511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of changes in the serum levels of lipids and lipoproteins in obese persons and in patients with diabetes mellitus type 2 associated with obesity].
    Jakubczyk D; Borejszo I; Kinalska I; Szelachowska M; Biedzińska M
    Pol Tyg Lek; 1985 Dec; 40(50):1395-7. PubMed ID: 3831988
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromatographic differentiation of nicotinamide riboside and 1-methylnicotinamide.
    Bernofsky C
    Anal Biochem; 1979 Mar; 93(2):384-5. PubMed ID: 157080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.